Particle and Fibre Toxicology | Articles which cite: Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy.

Log on/register
BioMed Central home | Journals A-Z | Feedback | Support | My details

Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy.
Oberdörster G, Maynard A, Donaldson K, Castranova V, Fitzpatrick J, Ausman K, Carter J, Karn B, Kreyling W, Lai D, Olin S, Monteiro-Riviere N, Warheit D, Yang H, ILSI Research Foundation/Risk Science Institute Nanomaterial Toxicity Screening Working Group
Part Fibre Toxicol 2005 Oct 6, 2:8
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]

printer friendly

to [Help]

PubMed Central articles that cite the above article:

1.	Single-walled carbon nanotube interactions with HeLa cells. Yehia HN, Draper RK, Mikoryak C, Walker EK, Bajaj P, Musselman IH, Daigrepont MC, Dieckmann GR, Pantano P J Nanobiotechnology 2007, 5:8 [PubMed Central] [PubMed] [Related articles]
2.	Nanoparticles: pharmacological and toxicological significance. Medina C, Santos-Martinez MJ, Radomski A, Corrigan OI, Radomski MW Br J Pharmacol 2007 Mar, 150:552-8 [PubMed Central] [PubMed] [Related articles]
3.	Unmodified CdSe quantum dots induce elevation of cytoplasmic calcium levels and impairment of functional properties of sodium channels in rat primary cultured hippocampal neurons. Tang M, Xing T, Zeng J, Wang H, Li C, Yin S, Yan D, Deng H, Liu J, Wang M, Chen J, Ruan DY Environ Health Perspect 2008 Jul, 116:915-22 [PubMed Central] [PubMed] [Related articles]
4.	Drug delivery and nanoparticles:applications and hazards. De Jong WH, Borm PJ Int J Nanomedicine 2008, 3:133-49 [PubMed Central] [PubMed] [Related articles]
5.	Pulmonary applications and toxicity of engineered nanoparticles. Card JW, Zeldin DC, Bonner JC, Nestmann ER Am J Physiol Lung Cell Mol Physiol 2008 Sep, 295:L400-11 [PubMed Central] [PubMed] [Related articles]
6.	Magnetic nanoparticles for theragnostics. Shubayev VI, Pisanic TR, Jin S Adv Drug Deliv Rev 2009 Jun 21, 61:467-77 [PubMed Central] [PubMed] [Related articles]
7.	Interactions between SIRT1 and AP-1 reveal a mechanistic insight into the growth promoting properties of alumina (Al2O3) nanoparticles in mouse skin epithelial cells. Dey S, Bakthavatchalu V, Tseng MT, Wu P, Florence RL, Grulke EA, Yokel RA, Dhar SK, Yang HS, Chen Y, St Clair DK Carcinogenesis 2008 Oct, 29:1920-9 [PubMed Central] [PubMed] [Related articles]
8.	In vitro assessments of nanomaterial toxicity. Jones CF, Grainger DW Adv Drug Deliv Rev 2009 Jun 21, 61:438-56 [PubMed Central] [PubMed] [Related articles]
9.	Biopersistence and potential adverse health impacts of fibrous nanomaterials: what have we learned from asbestos? Sanchez VC, Pietruska JR, Miselis NR, Hurt RH, Kane AB Wiley Interdiscip Rev Nanomed Nanobiotechnol 2009 Sep, 1:511-29 [PubMed Central] [PubMed] [Related articles]

This article is also cited by 9 articles in BioMed Central

printer friendly

to [Help]

Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us